One provision of the Lower Health Care Costs Act that has garnered significantly less attention from the broader healthcare community has raised concerns among many biologics stakeholders.
USP in the News
Unpublished data suggest that pharmacopeial quality standards, while not associated with increasing the likelihood of a first generic entrant in the market, are associated with increasing the overall number of generic entrants.
News Releases & Announcements
Quality Matters Blog
The digitization of healthcare must be effectively structured to optimize care, therapies, access, and outcomes.
Consistent quality. Greater access. They’re what patients deserve and what USP strives to ensure across the globe through the development of public quality standards.
USP standards have evolved to accommodate medicines of all types. The biosimilar paradigm may ultimately resemble that of generic drugs.